
Bioorganic and Medicinal Chemistry Letters p. 2009 - 2014 (1997)
Update date:2022-08-04
Topics:
Augelli-Szafran, Corinne E.
Purchase, Terri S.
Roth, Bruce D.
Tait, Bradley
Trivedi, Bharat K.
Wilson, Michael
Suman-Chauhan, Nirmala
Webdale, Louise
Due to the interesting pharmacological activity observed for CI-988, a potent and selective CCK-B receptor antagonist, we have continued to study the SAR of this antagonist. This particular study examines the importance of the indole moiety for binding affinity. The synthesis and receptor binding affinity for analogs containing functionalized indole derivatives and replacing the indole with various heterocycles are reported.
View MoreXiamen Kaijia Imp & Exp Co., Ltd.
Contact:86-592-5101177
Address:Room406 Luhui Building No. 65 Haitian Road Huli Xiamen,China.
Angelisun(Chongqing) Pharmaceutical Co., LTD.
Contact:+86-23-68030926-816
Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
SHUNYUANSHENG BIO-PHARMTECH CO., LTD
website:https://www.whsysbio.com
Contact:--
Address:Building 13, Liandong U Valley-Wuhan Economic Innovation Valley, No. 259, Xingsan Road, Shamao Street, Hannan District, Wuhan City, Hubei Province
Zhejiang Genebest Pharmaceutical Co.,Ltd.
Contact:0086-571-63532866
Address:No.1 Jinboshi Rd Lishan Town Fuyang City Zhejiang Province China
Contact:+852-8198 2399
Address:9E, Leapont Industrial Building, 18-28 Wo Liu Hang Road, Shatin, New Territories, Hong Kong
Doi:10.1021/co4000024
(2013)Doi:10.3762/bjoc.8.194
(2012)Doi:10.1016/j.poly.2012.06.080
(2013)Doi:10.1248/cpb.c18-00081
(2018)Doi:10.1515/hc-2016-0201
(2017)Doi:10.1007/BF00757658
()